What does CUSIP 488445206 represent in this 13F holders report?

CUSIP 488445206 is the security identifier for ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK in Q1 2026?

145 institutional investors reported ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK for Q1 2026. Use the holders table for investor-level position and value details.

ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA)

CUSIP: 488445206

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / COMMON STOCK
Shares outstanding: 58,397,755
Total 13F shares: 41,311,140
Share change: +3,118,555
Total reported value: $384,536,372
Put/Call ratio: 192%
Price per share: $9.32
Number of holders: 145
Value change: +$29,383,896
Number of buys: 66
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 488445206:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock, Inc.	13F 13D/G	Company	7.6% from 13D/G	4,507,051	$40,383,177	—	31 Dec 2025	13F 13D/G
Woodline Partners LP	13D/G 13F	Company	6.2%	3,476,143	$33,058,120	$0	30 Sep 2025	13D/G 13F
FMR LLC	13D/G 13F	Company	5.5%	3,211,877	$29,934,689	$0	31 Mar 2026	13D/G 13F
VANGUARD GROUP INC	13F	Company	5.7%	3,305,207	$29,614,655	—	31 Dec 2025	13F
Adage Capital Management, L.P.	13D/G	—	4%	2,225,000	$21,159,750	-$13,551,750	30 Sep 2025	13D/G
Nantahala Capital Management, LLC	13D/G 13F	Company	4.4%	2,340,333	$16,920,608	-$4,220,064	31 Dec 2024	13D/G 13F
Samuel J. Braun	3/4/5	10%+ Owner	— class O/S missing	3,153,000	$15,636,043	—	13 May 2021	3/4/5
STATE STREET CORP	13F	Company	2.5%	1,482,956	$13,287,286	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.3%	1,341,681	$12,024,511	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	2%	1,157,913	$10,374,901	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.9%	1,134,358	$10,163,848	—	31 Dec 2025	13F
Legal & General Group Plc	13F	Company	1.9%	1,097,988	$9,837,973	—	31 Dec 2025	13F
683 Capital Management, LLC	13F	Company	1.5%	905,000	$8,108,800	—	31 Dec 2025	13F
ROYCE & ASSOCIATES LP	13F	Company	1.5%	865,822	$7,757,765	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	1.5%	863,746	$7,739,164	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	1.4%	842,854	$7,551,972	—	31 Dec 2025	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	1.2%	692,097	$6,201,189	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	1.1%	669,742	$6,000,889	—	31 Dec 2025	13F
Retirement Planning Co of New England, Inc.	13F	Company	1.1%	662,976	$5,940,265	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	588,700	$5,274,752	—	31 Dec 2025	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	1%	585,069	$5,242,218	—	31 Dec 2025	13F
Stonepine Capital Management, LLC	13F	Company	0.97%	569,088	$5,099,028	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.97%	563,906	$5,052,598	—	31 Dec 2025	13F
Caption Management, LLC	13F	Company	0.92%	540,112	$4,839,404	—	31 Dec 2025	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.87%	506,033	$4,458,151	—	31 Dec 2025	13F
Neil F. McFarlane	3/4/5	President and CEO, Director	— mixed-class rows	712,225 mixed-class rows	$4,205,000	-$1,189,519	07 Feb 2026	3/4/5
NORTHERN TRUST CORP	13F	Company	0.72%	418,122	$3,746,373	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.71%	412,261	$3,693,858	—	31 Dec 2025	13F
Stratos Wealth Partners, LTD.	13F	Company	0.7%	409,000	$3,664,640	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.61%	356,243	$3,191,937	—	31 Dec 2025	13F
Mystic Asset Management, Inc.	13F	Company	0.59%	346,527	$3,104,882	—	31 Dec 2025	13F
Squarepoint Ops LLC	13F	Company	0.54%	317,066	$2,840,911	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.5%	293,095	$2,626,131	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.49%	285,488	$2,557,972	—	31 Dec 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.47%	275,000	$2,464,000	—	31 Dec 2025	13F
Trexquant Investment LP	13F	Company	0.36%	209,704	$1,878,948	—	31 Dec 2025	13F
Janney Montgomery Scott LLC	13F	Company	0.35%	202,883	$1,818,000	—	31 Dec 2025	13F
Tetragon Partners GP Ltd	13F	Company	0.33%	192,518	$1,724,961	—	31 Dec 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.31%	181,129	$1,622,916	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.31%	180,618	$1,618,337	—	31 Dec 2025	13F
Kovack Advisors, Inc.	13F	Company	0.3%	175,331	$1,570,966	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.3%	174,155	$1,560,427	—	31 Dec 2025	13F
R. LaDuane Clifton	3/4/5	Former CFO & Treasurer	— mixed-class rows	211,515 mixed-class rows	$1,555,014	—	31 Dec 2025	3/4/5
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.29%	170,309	$1,525,968	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.26%	154,466	$1,384,016	—	31 Dec 2025	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.26%	151,424	$1,356,759	—	31 Dec 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.26%	149,637	$1,338,000	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.25%	146,364	$1,311,422	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	0.25%	143,132	$1,282,463	—	31 Dec 2025	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.24%	139,591	$1,250,735	—	31 Dec 2025	13F

Institutional Holders of ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) as of Q1 2026

As of 31 Mar 2026, ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,311,140 shares. The largest 10 holders included BlackRock, Inc., Woodline Partners LP, FMR LLC, Nantahala Capital Management, LLC, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, AIGH Capital Management LLC, MORGAN STANLEY, and Legal & General Group Plc. This page lists 146 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

158

Q1 2026 holders

145

Holder diff

-13

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.